Evidence map›Paper›PMID 30808425›Full record

ArticleGenome medicine2019

Predispositional genome sequencing in healthy adults: design, participant characteristics, and early outcomes of the PeopleSeq Consortium.

Emilie S Zoltick, Michael D Linderman, Molly A McGinniss, Erica Ramos, Madeleine P Ball, George M Church, Debra G B Leonard, Stacey Pereira, Amy L McGuire, C Thomas Caskey and 6 more

Abstract read
In one paragraph

Article in Genome medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Elective genomic sequencing for adults in research, clinical and commercial contexts.medRxiv : the preprint server for health sciences · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Primary Care Providers' Experiences With an Active Elective Genetic Testing Program.Health education & behavior : the official publication of the Society for Public Health Education · 2025
    Article
  12. Article
  13. Attitudes, knowledge, and risk perceptions of patients who received elective genomic testing as a clinical service.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Perspectives of diverse Spanish- and English-speaking patients on the clinical use of polygenic risk scores.Genetics in medicine : official journal of the American College of Medical Genetics · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Emilie S ZoltickDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, 41 Avenue Louis Pasteur, Suite 301, Boston, MA, 02115, USA.
Michael D LindermanDepartment of Computer Science, Middlebury College, McCardell Bicentennial Hall, Middlebury, VT, 05753, USA.
Molly A McGinnissIllumina, Inc, 5200 Illumina Way, San Diego, CA, 92122, USA.
Erica RamosGeisinger National Precision Health, Geisinger, 6101 Executive Blvd, Suite 110, North Bethesda, MD, 20852, USA.
Madeleine P BallOpen Humans Foundation, Boston, MA, USA.
George M ChurchOpen Humans Foundation, Boston, MA, USA.
Debra G B LeonardDepartment of Pathology and Laboratory Medicine, Robert Larner, M.D, College of Medicine of the University of Vermont, 89 Beaumont Avenue, Courtyard at Given S269, Burlington, VT, 05405, USA.
Stacey PereiraCenter for Medical Ethics and Health Policy, Baylor College of Medicine, One Baylor Plaza, Suite 310D, Houston, TX, 77030, USA.
Amy L McGuireCenter for Medical Ethics and Health Policy, Baylor College of Medicine, One Baylor Plaza, Suite 310D, Houston, TX, 77030, USA.
C Thomas CaskeyMolecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Mail Stop BCM225, Houston, TX, 77030, USA.
Saskia C SandersonDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1498, New York, NY, 10029, USA.
Eric E SchadtDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1498, New York, NY, 10029, USA.
Daiva E NielsenDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, 41 Avenue Louis Pasteur, Suite 301, Boston, MA, 02115, USA.
Scott D CrawfordSoundRocket, 950 Victors Way, Suite 50, Ann Arbor, MI, 48108, USA.
Robert C GreenDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, 41 Avenue Louis Pasteur, Suite 301, Boston, MA, 02115, USA. rcgreen@bwh.harvard.edu.
PeopleSeq Consortium

Funding

Finding Genomic Profiles of COVID-19 Phenotypes from the EHRU01HG008685 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIZABETH W KARLSON, Matthew S Lebo · 2015 to 2026
$13.6M
Integration of Whole Genome Sequencing into Clinical MedicineU01HG006500 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI GREEN, ROBERT C. · 2012 to 2016
$11.5M
Genome Sequence-Based Screening for Childhood Risk and Newborn IllnessU19HD077671 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI BEGGS, ALAN H., GREEN, ROBERT C. · 2013 to 2018
$6.1M
Multidisciplinary Training Program in Cardiovascular EpidemiologyT32HL125232 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Matthew G. Nayor, Vanessa Xanthakis · 2016 to 2026
$5.0M
Experiences and Outcomes in Early Adopters of Predispositional SequencingR01HG009922 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI GREEN, ROBERT C. · 2018 to 2020
$2.6M
Developing a Genomics Literacy MeasureR03HG008809 · NHGRI · MIDDLEBURY COLLEGE · PI LINDERMAN, MICHAEL DAVID · 2016 to 2017
$128k
CIHRNHGRI NIH HHS R01 HG009922NHGRI NIH HHS R03 HG008809NHGRI NIH HHS R03-HG008809NHGRI NIH HHS U01 HG006500NHGRI NIH HHS U01-HG006500NHGRI NIH HHS U01 HG008685NHGRI NIH HHS U01-HG008685NHLBI NIH HHS T32 HL125232NHLBI NIH HHS T32-HL125232NICHD NIH HHS U19 HD077671NICHD NIH HHS U19-HD077671NIH HHS UG3-OD023156
6 · The paper itself

Abstract

backgroundIncreasing numbers of healthy individuals are undergoing predispositional personal genome sequencing. Here we describe the design and early outcomes of the PeopleSeq Consortium, a multi-cohort collaboration of predispositional genome sequencing projects, which is examining the medical, behavioral, and economic outcomes of returning genomic sequencing information to healthy individuals.

methodsApparently healthy adults who participated in four of the sequencing projects in the Consortium were included. Web-based surveys were administered before and after genomic results disclosure, or in some cases only after results disclosure. Surveys inquired about sociodemographic characteristics, motivations and concerns, behavioral and medical responses to sequencing results, and perceived utility.

resultsAmong 1395 eligible individuals, 658 enrolled in the Consortium when contacted and 543 have completed a survey after receiving their genomic results thus far (mean age 53.0 years, 61.4% male, 91.7% white, 95.5% college graduates). Most participants (98.1%) were motivated to undergo sequencing because of curiosity about their genetic make-up. The most commonly reported concerns prior to pursuing sequencing included how well the results would predict future risk (59.2%) and the complexity of genetic variant interpretation (56.8%), while 47.8% of participants were concerned about the privacy of their genetic information. Half of participants reported discussing their genomic results with a healthcare provider during a median of 8.0 months after receiving the results; 13.5% reported making an additional appointment with a healthcare provider specifically because of their results. Few participants (< 10%) reported making changes to their diet, exercise habits, or insurance coverage because of their results. Many participants (39.5%) reported learning something new to improve their health that they did not know before. Reporting regret or harm from the decision to undergo sequencing was rare (< 3.0%).

conclusionsHealthy individuals who underwent predispositional sequencing expressed some concern around privacy prior to pursuing sequencing, but were enthusiastic about their experience and not distressed by their results. While reporting value in their health-related results, few participants reported making medical or lifestyle changes.

Indexed as

Genetic TestingHealth Knowledge, Attitudes, PracticeWhole Genome SequencingAdultAgedAged, 80 and overFemaleGenetic Predisposition to DiseaseHumansMaleMiddle AgedMotivationPrecision MedicineSurveys and QuestionnairesGenomicsPersonal genome sequencingPublic healthReturn of resultsTest utility

Identifiers

PMID30808425
PMCPMC6391825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.